Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydronidone Capsules in Patients With Liver Fibrosis
NCT07364448Phase 2Completed
- Sponsor
- Gyre Pharmaceuticals
- Start
- Mar 2026
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydronidone in Liver Fibrosis (LF), sponsored by Gyre Pharmaceuticals. Started Mar 2026; status: completed.
02
Drugs
hydronidone
03
Conditions
Liver Fibrosis (LF)
Beyond the preview
Go deeper on NCT07364448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07364448.